Join the Acute Lymphoblastic Leukemia group to help and get support from people like you.
Acute Lymphoblastic Leukemia News (Page 3)
FDA Approves Purixan (mercaptopurine) Oral Suspension
April 29, 2014 – On April 28, 2014, the U. S. Food and Drug Administration approved an oral suspension of mercaptopurine (Purixan, NOVA Laboratories Limited). Mercaptopurine is a 20 mg/ml oral...
FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia
January 25, 2013 – The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute...
FDA Approves Iclusig to Treat Two Rare Types of Leukemia
December 14, 2012 - The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute...
FDA Approves Marqibo for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia
August 9, 2012 – The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome...
FDA Approves Erwinaze to Treat Acute Lymphoblastic Leukemia
November 18, 2011 – The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an...
FDA approves additional medical indication for Sprycel
SILVER SPRING, Md., Oct. 28 - The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The...